TEVA250516P24000
- 0.00
- 0.000.00%
Teva Pharmaceutical Industries Newsroom
Teva Pharmaceutical Industries Options Spot-On: On May 12th, 93,396 Contracts Were Traded, With 1.12 Million Open Interest
Teva Pharmaceutical Industries(TEVA.US) Officer Sells US$6.1 Million in Common Stock
Sector Update: Health Care Stocks Advance Late Afternoon
Sector Update: Health Care
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
This Wayfair Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Teva Pharmaceuticals Raised to Overweight From Neutral by JP Morgan
Today's Analyst Rating | MercadoLibre Price Target Raised to $2850 by Morgan Stanley, McKesson Price Target Raised to $820 by TD Cowen
J.P. Morgan Upgrades Teva Pharmaceutical Industries(TEVA.US) to Buy Rating, Announces Target Price $23
Express News | Teva’s 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
Teva's 2024 Healthy Future Report Highlights Sustainability Progress, Including Surpassed Targets Linked to Financial Strategy
Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means
Express News | Teva : JP Morgan Raises to Overweight From Neutral; Raises Target Price to $23 From $21
Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
Trump Says He'll Sign Executive Order to Lower Prescription-drug Prices
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Fly 26% But Investors Aren't Buying For Growth
Leader Capital Markets Sticks to Their Buy Rating for Teva (TEVA)
Teva Pharmaceutical Industries Limited (TEVA): Among Billionaire Larry Robbins' Stock Picks With Huge Upside Potential
Research Alert: CFRA Maintains Sell Opinion On Shares Of Teva Pharmaceutical Industries
Express News | Form 144 | Teva Pharmaceutical Industries(TEVA.US) Officer Proposes to Sell 6.1 Million in Common Stocks